These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 26240026

  • 21. Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.
    Brahma B, Yulian ED, Ramli M, Setianingsih I, Gautama W, Brahma P, Sastroasmoro S, Harimurti K.
    Asian Pac J Cancer Prev; 2013; 14(1):31-7. PubMed ID: 23534744
    [Abstract] [Full Text] [Related]

  • 22. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [Abstract] [Full Text] [Related]

  • 23. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 24. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
    Park SJ, Sun JY, Hong K, Kwak JY, Kim EK, Chung WY, Choi JR.
    Clin Chem Lab Med; 2013 Aug; 51(8):1673-80. PubMed ID: 23585181
    [Abstract] [Full Text] [Related]

  • 25. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D.
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [Abstract] [Full Text] [Related]

  • 26. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
    Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.
    Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
    [Abstract] [Full Text] [Related]

  • 27. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation.
    Araujo PP, Marcello MA, Tincani AJ, Guilhen AC, Morari EC, Ward LS.
    Pathol Res Pract; 2012 Aug 15; 208(8):489-92. PubMed ID: 22770943
    [Abstract] [Full Text] [Related]

  • 28. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.
    Clin Chem Lab Med; 2011 Feb 15; 49(2):325-9. PubMed ID: 21175381
    [Abstract] [Full Text] [Related]

  • 29. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP, Kozlova VM, Kondrat'eva TT, Pavlovskaia AI, Marakhonov AV, Baranova AV, Ivanova NI, Stepanova AA, Poliakov AV, Belev NF, Brzhezovskiĭ VZh.
    Arkh Patol; 2014 Feb 15; 76(5):3-12. PubMed ID: 25543402
    [Abstract] [Full Text] [Related]

  • 30. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C.
    Thyroid; 2007 Nov 15; 17(11):1109-15. PubMed ID: 17727338
    [Abstract] [Full Text] [Related]

  • 31. The value of the repeated examination of BRAF V600E mutation status in diagnostics of papillary thyroid cancer.
    Beiša A, Beiša V, Stoškus M, Ostanevičiūtė E, Griškevičius L, Strupas K.
    Endokrynol Pol; 2016 Nov 15; 67(1):35-40. PubMed ID: 26884113
    [Abstract] [Full Text] [Related]

  • 32. BRAF mutation in fine-needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area.
    Moon HJ, Kim EK, Chung WY, Shin DY, Kwak JY.
    Head Neck; 2015 Oct 15; 37(10):1432-8. PubMed ID: 24838814
    [Abstract] [Full Text] [Related]

  • 33. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K.
    Exp Clin Endocrinol Diabetes; 2019 Apr 15; 127(4):247-254. PubMed ID: 29566402
    [Abstract] [Full Text] [Related]

  • 34. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun 15; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 35. Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.
    Guo HQ, Zhao H, Zhang ZH, Zhu YL, Xiao T, Pan QJ.
    Dis Markers; 2014 Jun 15; 2014():912182. PubMed ID: 24591770
    [Abstract] [Full Text] [Related]

  • 36. The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Strupas K.
    Langenbecks Arch Surg; 2017 Mar 15; 402(2):227-234. PubMed ID: 28160058
    [Abstract] [Full Text] [Related]

  • 37. CD117: a novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies.
    Pusztaszeri MP, Sadow PM, Faquin WC.
    Cancer Cytopathol; 2014 Aug 15; 122(8):596-603. PubMed ID: 24920192
    [Abstract] [Full Text] [Related]

  • 38. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M, Granitto A, Martini M, Capodimonti S, Cocomazzi A, Musarra T, Fiorentino V, Pontecorvi A, Lombardi CP, Fadda G, Pantanowitz L, Larocca LM, Rossi ED.
    Cancer Cytopathol; 2020 Mar 15; 128(3):177-189. PubMed ID: 31821747
    [Abstract] [Full Text] [Related]

  • 39. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 15; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 40. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
    Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.
    Thyroid; 2011 Jul 15; 21(7):717-23. PubMed ID: 21568726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.